TRIANNI
Summary
Trianni is a company that specializes in antibody discovery technology using transgenic mice.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 66 M
Avg. Deal Size£ 66 M
All rights reserved. Copyright © 2025 Datasite
Summary
Trianni is a company that specializes in antibody discovery technology using transgenic mice.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Matthias Wabl
Chairman and CEO